Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of ...

Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...

The human body is teeming with trillions of symbiotic microorganisms, profoundly impacting our well-being. Within the gut, ...

A study from Emory University suggests that an anti-inflammatory drug called ketorolac might help stop cancer metastasis if ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3 ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...

Innovative technologies such as artificial intelligence (AI), machine learning, and quantum computing can accelerate the design and discovery of novel drugs ... can create anti-cancer molecules ...